- Home
- VSA vs IMRN Comparison
VSA vs IMRN Comparison
Compare VSA & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSA
- IMRN
- Stock Information
- Founded
- VSA 2002
- IMRN 1994
- Country
- VSA China
- IMRN Australia
- Employees
- VSA N/A
- IMRN N/A
- Industry
- VSA
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- VSA
- IMRN Health Care
- Exchange
- VSA NYSE
- IMRN Nasdaq
- Market Cap
- VSA 7.8M
- IMRN 9.2M
- IPO Year
- VSA N/A
- IMRN N/A
- Fundamental
- Price
- VSA $0.80
- IMRN $1.76
- Analyst Decision
- VSA
- IMRN Strong Buy
- Analyst Count
- VSA 0
- IMRN 1
- Target Price
- VSA N/A
- IMRN $5.00
- AVG Volume (30 Days)
- VSA 228.6K
- IMRN 51.0K
- Earning Date
- VSA 06-13-2025
- IMRN 06-10-2025
- Dividend Yield
- VSA N/A
- IMRN N/A
- EPS Growth
- VSA N/A
- IMRN N/A
- EPS
- VSA N/A
- IMRN N/A
- Revenue
- VSA $160,411,283.00
- IMRN $4,048,286.00
- Revenue This Year
- VSA N/A
- IMRN N/A
- Revenue Next Year
- VSA N/A
- IMRN N/A
- P/E Ratio
- VSA N/A
- IMRN N/A
- Revenue Growth
- VSA N/A
- IMRN 82.90
- 52 Week Low
- VSA $0.18
- IMRN $1.50
- 52 Week High
- VSA $2.00
- IMRN $2.87
- Technical
- Relative Strength Index (RSI)
- VSA N/A
- IMRN 47.16
- Support Level
- VSA N/A
- IMRN $1.63
- Resistance Level
- VSA N/A
- IMRN $1.95
- Average True Range (ATR)
- VSA 0.00
- IMRN 0.18
- MACD
- VSA 0.00
- IMRN -0.00
- Stochastic Oscillator
- VSA 0.00
- IMRN 56.28
About VSA TCTM KIDS IT EDUCATION INC SPON ADS EA REP 5 ORD SHS(POST REV SPLT)
TCTM Kids IT Education Inc engages in the provision of IT-focused education services in Mainland China. The company has two operating segments: the IT Professional Education segment and the IT-focused Supplementary STEM Education Services segment. It offers supplementary science, technology, engineering, and mathematics (STEM) education programs to young children aged between three and eighteen through online teaching models and instructors from online or offline learning centers. The company also operates an education platform that offers distance instruction, classroom-based learning, and online learning modules.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.